Shaheen Emmanuel Lakhan MD PhD, FAAN (He/Him)

Summary

• Shaheen E. Lakhan, MD, PhD, FAAN, is a physician-scientist, entrepreneur, and biotech executive dedicated to advancing neuroscience and digital health innovation. He is the Founder of Boricua Bio, a Puerto Rico–based biotechnology company focused on building next-generation therapeutics at the intersection of brain, behavior, and technology.
  
  Dr. Lakhan previously served as Chief Medical & Scientific Officer at Click Therapeutics, where he led the development of software-based prescription digital therapeutics across neurology, psychiatry, cardiometabolic, and oncology indications. Under his leadership, Click achieved multiple FDA clearances, Breakthrough Device designations, and pivotal partnerships with Boehringer Ingelheim, Otsuka, and Indivior.
  
  Board-certified in neurology and pain medicine with training from the Cleveland Clinic and Massachusetts General Hospital, Dr. Lakhan has advanced novel drugs, devices, and digital therapeutics from concept to market. He has held leadership roles in academia and industry, including founding department chair and dean at the California University of Science and Medicine, and faculty appointments at Harvard Medical School and Case Western Reserve University.
  
  He has authored over 100 peer-reviewed publications and books and has been recognized with the Harvard Medical School Dean’s Community Service Award, the U.S. Presidential Lifetime Achievement Award, and the Congressional Gold Medal. A Fellow of the American Academy of Neurology, Dr. Lakhan continues to integrate science, compassion, and innovation to democratize access to high-quality, data-driven healthcare.


Industry Insights: Shaheen Lakhan - DTx East